99 related articles for article (PubMed ID: 10706395)
21. Preparation of polyclonal antibodies to an anti-tumor (1----3)-beta-D-glucan, schizophyllan.
Tabata K; Itoh W; Hirata A; Sugawara I; Mori S
Agric Biol Chem; 1990 Aug; 54(8):1953-9. PubMed ID: 1368605
[TBL] [Abstract][Full Text] [Related]
22. Immunopharmacological characterization of a highly branched fungal (1-->3)-beta-D-glucan, OL-2, isolated from Omphalia lapidescens.
Ohno N; Saito K; Nemoto J; Kaneko S; Adachi Y; Nishijima M; Miyazaki T; Yadomae T
Biol Pharm Bull; 1993 Apr; 16(4):414-9. PubMed ID: 8358393
[TBL] [Abstract][Full Text] [Related]
23. Schizophyllan (SPG)-treated macrophages and anti-tumor activities against syngeneic and allogeneic tumor cells. I. Characteristics of SPG-treated macrophages.
Sugawara I; Lee KC; Wong M
Cancer Immunol Immunother; 1984; 16(3):137-44. PubMed ID: 6322974
[TBL] [Abstract][Full Text] [Related]
24. Enhancement of cytokine production by macrophages stimulated with (1-->3)-beta-D-glucan, grifolan (GRN), isolated from Grifola frondosa.
Adachi Y; Okazaki M; Ohno N; Yadomae T
Biol Pharm Bull; 1994 Dec; 17(12):1554-60. PubMed ID: 7537572
[TBL] [Abstract][Full Text] [Related]
25. Effect of sizofiran on regional lymph nodes in patients with head and neck cancer.
Kano Y; Kakuta H; Hashimoto J
Biotherapy; 1996; 9(4):257-62. PubMed ID: 9012545
[TBL] [Abstract][Full Text] [Related]
26. Analysis of cytokine mRNAs induced by the administration of a highly branched (1-->3)-beta-D-glucan, OL-2.
Nemoto J; Ohno N; Saito K; Adachi Y; Yadomae T
Biol Pharm Bull; 1994 Jul; 17(7):948-54. PubMed ID: 8000384
[TBL] [Abstract][Full Text] [Related]
27. Pharmaceutical Production of Anti-tumor and Immune-potentiating Enterococcus faecalis-2001 β-glucans: Enhanced Activity of Macrophage and Lymphocytes in Tumor-implanted Mice.
Gu YH; Choi H; Yamashita T; Kang KM; Iwasa M; Lee MJ; Lee KH; Kim CH
Curr Pharm Biotechnol; 2017 Nov; 18(8):653-661. PubMed ID: 28969561
[TBL] [Abstract][Full Text] [Related]
28. Immunopharmacological activity of the purified insoluble glucan, zymocel, in mice.
Suzuki T; Ohno N; Chiba N; Miura NN; Adachi Y; Yadomae T
J Pharm Pharmacol; 1996 Dec; 48(12):1243-8. PubMed ID: 9004185
[TBL] [Abstract][Full Text] [Related]
29. Comparison of the blood clearance of triple- and single-helical schizophyllan in mice.
Miura NN; Ohno N; Adachi Y; Aketagawa J; Tamura H; Tanaka S; Yadomae T
Biol Pharm Bull; 1995 Jan; 18(1):185-9. PubMed ID: 7735240
[TBL] [Abstract][Full Text] [Related]
30. Effects of 10-hydroxy-2-decenoic acid on phagocytosis and cytokines production of peritoneal macrophages in vitro.
Wang GY; Lin ZB
Zhongguo Yao Li Xue Bao; 1997 Mar; 18(2):180-2. PubMed ID: 10072977
[TBL] [Abstract][Full Text] [Related]
31. Modulation of immune effector cell cytolytic activity and tumour growth inhibition in vivo by Ukrain (NSC 631570).
Liepins A; Nowicky JW
Drugs Exp Clin Res; 1996; 22(3-5):103-13. PubMed ID: 8899312
[TBL] [Abstract][Full Text] [Related]
32. [Antitumor activity of schizophyllan (SPG) against syngeneic ACI/N rat tumor, AMC-60 fibrosarcoma and BC-47 bladder cancer].
Mitani M; Arika T; Matsuo T; Asano T
Gan To Kagaku Ryoho; 1984 Sep; 11(9):1809-17. PubMed ID: 6236752
[TBL] [Abstract][Full Text] [Related]
33. Rheological properties and antitumor activity of schizophyllan produced with solid-state fermentation.
Zhong K; Liu L; Tong L; Zhong X; Wang Q; Zhou S
Int J Biol Macromol; 2013 Nov; 62():13-7. PubMed ID: 23973493
[TBL] [Abstract][Full Text] [Related]
34. Cooperative role of T lymphocytes and macrophages in anti-tumor activity of mice pretreated with schizophyllan (SPG).
Suzuki M; Arika T; Amemiya K; Fujiwara M
Jpn J Exp Med; 1982 Apr; 52(2):59-65. PubMed ID: 6214649
[TBL] [Abstract][Full Text] [Related]
35. Immunotoxicity of soluble beta-glucans induced by indomethacin treatment.
Yoshioka S; Ohno N; Miura T; Adachi Y; Yadomae T
FEMS Immunol Med Microbiol; 1998 Jul; 21(3):171-9. PubMed ID: 9718206
[TBL] [Abstract][Full Text] [Related]
36. Effect of SPG/indomethacin treatment on sepsis, interleukin-6 production, and expression of hepatic cytochrome P450 isoforms in differing strains of mice.
Saito M; Nameda S; Miura NN; Adachi Y; Ohno N
J Immunotoxicol; 2009 Mar; 6(1):42-8. PubMed ID: 19519162
[TBL] [Abstract][Full Text] [Related]
37. Immunization with antigenic peptides complexed with β-glucan induces potent cytotoxic T-lymphocyte activity in combination with CpG-ODNs.
Mochizuki S; Morishita H; Kobiyama K; Aoshi T; Ishii KJ; Sakurai K
J Control Release; 2015 Dec; 220(Pt A):495-502. PubMed ID: 26562685
[TBL] [Abstract][Full Text] [Related]
38. The anti-tumor effect of Ganoderma lucidum is mediated by cytokines released from activated macrophages and T lymphocytes.
Wang SY; Hsu ML; Hsu HC; Tzeng CH; Lee SS; Shiao MS; Ho CK
Int J Cancer; 1997 Mar; 70(6):699-705. PubMed ID: 9096652
[TBL] [Abstract][Full Text] [Related]
39. Expression of interleukin 1 family mRNAs by a highly branched (1-->3)-beta-D-glucan, OL-2.
Nemoto J; Ohno N; Saito K; Adachi Y; Yadomae T
Biol Pharm Bull; 1993 Oct; 16(10):1046-50. PubMed ID: 8287038
[TBL] [Abstract][Full Text] [Related]
40. Immunoregulatory effects of sizofiran (SPG) on lymphocytes and polymorphonuclear leukocytes.
Yoneda K; Ueta E; Yamamoto T; Osaki T
Clin Exp Immunol; 1991 Nov; 86(2):229-35. PubMed ID: 1657462
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
